The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment
Open accessAbstract
In the past two decades, several advancements have improved the care of HIV-infected individuals. Most importantly, the development and deployment of combination antiretroviral therapy (CART) has resulted in a dramatic decline in the rate of deaths from AIDS, so that people living with HIV today have nearly normal life expectancies if treated with CART. The term HIV-associated neurocognitive disorder (HAND) has been used to describe the spectrum of neurocognitive dysfunction associated with HIV infection. HIV can enter the CNS during early stages of infection, and persistent CNS HIV infection and inflammation probably contribute to the development of HAND. The brain can subsequently serve as a sanctuary for ongoing HIV replication, even when systemic viral suppression has been achieved. HAND can remain in patients treated with CART, and its effects on survival, quality of life and everyday functioning make it an important unresolved issue. In this Review, we describe the epidemiology of HAND, the evolving concepts of its neuropathogenesis, novel insights from animal models, and new approaches to treatment. We also discuss how inflammation is sustained in chronic HIV infection. Moreover, we suggest that adjunctive therapies — treatments targeting CNS inflammation and other metabolic processes, including glutamate homeostasis, lipid and energy metabolism — are needed to reverse or improve HAND-related neurological dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–223 of 223
Lentz, M. R., Peterson, K. L., Ibrahim, W. G., Lee, D. E., Sarlls, J. E., Lizak, M. J., Maric, D., Reid, W. C., & Hammoud, D. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105752 · Cited by 34
Brown, A. M. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0049-2 · Cited by 32
Self-citationon behalf of the ACTG A5235 team, Sacktor, N. C., Miyahara, S., Evans, S. R., Schifitto, G., Cohen, B. A., Haughey, N. J., Drewes, J. L., Graham, D., Zink, M. C., et al. (2014) · Journal of NeuroVirology · doi:10.1007/s13365-014-0292-0 · Cited by 31
Self-citationPaving the path to HIV neurotherapy: Predicting SIV CNS disease
Beck, S. E., Queen, S. E., Witwer, K. W., Pate, K. A. M., Mangus, L. M., Gama, L., Adams, R. J., Clements, J. E., Zink, M. C., & Mankowski, J. L. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.018 · Cited by 30
Self-citationNitrosative stress with HIV dementia causes decreased L-prostaglandin D synthase activity
Li, W., Malpica-Llanos, T., Gundry, R. L., Cotter, R. J., Sacktor, N. C., McArthur, J. C., & Nath, A. (2007) · Neurology · doi:10.1212/01.wnl.0000282761.19578.35 · Cited by 30
Self-citationGill, A. J., Kovacsics, C. E., Vance, P. J., Collman, R. G., & Kolson, D. L. (2015) · Journal of Virology · doi:10.1128/jvi.01495-15 · Cited by 30
Behavioral Animal Models to Assess Pro-cognitive Treatments for Schizophrenia
Young, J. W., Amitai, N., & Geyer, M. A. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_3 · Cited by 29
Kwasa, J. K., Saylor, D. R., Lwanya, E., Osiemo, D., Oyaro, P., Birbeck, G. L., Price, R. W., Bukusi, E. A., Cohen, C. R., & Meyer, A.-C. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032898 · Cited by 29
Self-citationEtherton, M. R., Lyons, J. L., & Ard, K. L. (2015) · Current Infectious Disease Reports · doi:10.1007/s11908-015-0485-6 · Cited by 29
The cerebrospinal fluid proteome in HIV infection: change associated with disease severity
Angel, T. E., Jacobs, J., Spudich, S., Gritsenko, M. A., Fuchs, D., Liegler, T. J., Zetterberg, H., Camp, D., Price, R. W., & Smith, R. D. (2012) · Clinical Proteomics · doi:10.1186/1559-0275-9-3 · Cited by 28
for the CHARTER Group, Hammond, E. R., Crum, R. M., Treisman, G. J., Mehta, S. H., Clifford, D. B., Ellis, R. J., Gelman, B. B., Grant, I., Letendre, S. L., et al. (2016) · Journal of NeuroVirology · doi:10.1007/s13365-015-0416-1 · Cited by 28
Self-citationMixed membership trajectory models of cognitive impairment in the multicenter AIDS cohort study
Molsberry, S. A., Lecci, F., Kingsley, L., Junker, B. W., Reynolds, S. M., Goodkin, K., Levine, A. J., Martin, E. M., Miller, E. N., Munro, C. A., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000561 · Cited by 26
Self-citationGraham, D. R. M., Gama, L., Queen, S. E., Li, M., Brice, A. K., Kelly, K. M., Mankowski, J. L., Clements, J. E., & Zink, M. C. (2010) · Journal of NeuroVirology · doi:10.1007/s13365-010-0005-2 · Cited by 26
Self-citationThomas, A. G., Sattler, R., TenDyke, K., Loiacono, K. A., Hansen, H. F., Sahni, V., Hashizume, Y., Rojas, C. J., & Slusher, B. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127785 · Cited by 25
Self-citationSnigdha, S., Milgram, N. W., Willis, S. L., Albert, M. S., Weıntraub, S., Fortin, N. J., & Cotman, C. W. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.01.018 · Cited by 25
Schuenke, K. W., & Gelman, B. B. (2003) · Journal of NeuroVirology · doi:10.1080/13550280390201056 · Cited by 25
Hadas, E., Chao, W., He, H., Saini, M., Daley, E., Saifuddin, M., Bentsman, G., Ganz, E., Volsky, D. J., & Potash, M. J. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.012617 · Cited by 24
Self-citationMarcondes, M. C. G., Flynn, C. T., Huitrón‐Reséndiz, S., Watry, D. D., Zandonatti, M. A., & Fox, H. S. (2009) · AIDS · doi:10.1097/qad.0b013e32832c4af0 · Cited by 23
Identification and Evaluation of New Primer Sets for the Detection of Lentivirus Proviral DNA
Gelman, I. H., Zhang, J., Hailman, E., Hanafusa, H., & Morse, S. S. (1992) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1992.8.1981 · Cited by 23
Vo, Q., Cox, C., Li, X., et al. (2012) · Journal of NeuroVirology · doi:10.1007/s13365-012-0136-8 · Cited by 20
Kelly, S. G., Taiwo, B., Wu, Y. G., Bhatia, R., Kettering, C. S., Gao, Y., Li, S., Hutten, R. J., & Ragin, A. B. (2014) · Journal of NeuroVirology · doi:10.1007/s13365-014-0261-7 · Cited by 20
Ratai, E., Pilkenton, S. J., He, J., Fell, R., Bombardier, J. P., Joo, C., Lentz, M. R., Kim, W.-K., Burdo, T. H., Autissier, P., et al. (2011) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.2011.00475.x · Cited by 17
Brain morphometric correlates of metabolic variables in HIV: the CHARTER study
for the CHARTER Group, Archibald, S. L., McCutchan, J. A., Sanders, C. M., Wolfson, T. J., Jernigan, T. L., Ellis, R. J., Ances, B. M., Collier, A. C., McArthur, J. C., et al. (2014) · Journal of NeuroVirology · doi:10.1007/s13365-014-0284-0 · Cited by 14
Self-citation
Cited by
Inflammasome signalling in brain function and neurodegenerative disease
Heneka, M. T., McManus, R. M., & Latz, E. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0055-7 · Cited by 836
NLRP3 Inflammasome—A Key Player in Antiviral Responses
Zhao, C., & Zhao, W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00211 · Cited by 432
Erickson, M. A., & Banks, W. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014647 · Cited by 378
Global prevalence and burden of HIV-associated neurocognitive disorder: A meta-analysis
Wang, Y., Liu, M., Lu, Q., Farrell, M., Lappin, J. M., Shi, J., Lu, L., & Bao, Y. (2020) · Neurology · doi:10.1212/wnl.0000000000010752 · Cited by 348
Dopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 308
Metadata
- Authors
- Saylor, D., Dickens, A. M., Sacktor, N., Haughey, N., Slusher, B., Pletnikov, M., Mankowski, J. L., Brown, A., Volsky, D. J., & McArthur, J. C.
- Venue
- Nature Reviews Neurology
- Published
- 2016-03-11
- Volume
- 12
- Issue
- 4
- Pages
- 234-248
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- OpenAlex
- W2295774726
- Cited by
- 1,036
- References
- 223
- FWCI
- 9.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.